Bupivacaine Impurity 13

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	APB533244
CAS	533-24-4
Molecular Weight	180.25
Molecular Formula	C11H16O2

What is the name of the impurity with CAS number 533-24-4?

The impurity is named Bupivacaine Impurity 13.

What is the molecular weight of Bupivacaine Impurity 13?

The molecular weight of Bupivacaine Impurity 13 is 180.25.

What is the molecular formula of Bupivacaine Impurity 13?

The molecular formula of Bupivacaine Impurity 13 is C11H16O2.

How is Bupivacaine Impurity 13 related to bupivacaine?

Bupivacaine Impurity 13 is an impurity of bupivacaine, which means it is a substance that is present in the bupivacaine drug product but is not the intended active ingredient.

What is the significance of identifying and quantifying impurities like Bupivacaine Impurity 13 in pharmaceuticals?

Identifying and quantifying impurities like Bupivacaine Impurity 13 is important for ensuring the safety, efficacy, and quality of pharmaceutical products.

What methods are commonly used to detect impurities in pharmaceuticals?

Methods such as chromatography, spectroscopy, and mass spectrometry are commonly used to detect impurities in pharmaceuticals.

How can the presence of impurities affect the purity and potency of a pharmaceutical product?

The presence of impurities can reduce the purity and potency of a pharmaceutical product, potentially compromising its effectiveness or causing harmful side effects.

Are there regulations in place that specify acceptable levels of impurities in pharmaceutical products?

Yes, regulatory agencies such as the FDA and EMA specify acceptable limits for impurities in pharmaceutical products to ensure their safety and quality.

How can impurities like Bupivacaine Impurity 13 be removed from pharmaceutical products?

Impurities can be removed from pharmaceutical products through various purification processes such as crystallization, distillation, or filtration.

What measures can be taken to prevent the formation of impurities during the manufacturing and storage of pharmaceutical products?

Good manufacturing practices, proper storage conditions, and regular quality control testing can help prevent the formation of impurities during the manufacturing and storage of pharmaceutical products.

* Products or Services Interested: Bupivacaine Impurity 13 (533-24-4)
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry